Restore Medical
Catheter-delivered Implant for Congestive Heart Failure
StartupRestore Medical is a Or Yehuda-based startup in the Health Tech & Life Sciences sector, established in 2015. Catheter-delivered Implant for Congestive Heart Failure. The company has raised a total of $29.43M across 5 funding rounds, currently at the B stage. Restore Medical was founded by Elchanan Bruckheimer and Stephen Bellomo. Key investors include Pitango HealthTech, Peregrine Ventures, European Union’s EIC Fund. The company has 11-50 employees. Core technologies: Materials & Substances, Implants.
With $29.43M in total funding, Restore Medical is a B-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageB
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQOr Yehuda
- DistrictCenter District
- Last Round$23M
- Pitango HealthTechLead
- Peregrine Ventures
- European Union’s EIC Fund
Elchanan BruckheimerCo-founder & CMO
Stephen BellomoCo-founder & VP Clinical Afffairs
8 articles covered by sources including www.globes.co.il,
www.geektime.co.il,
www.prnewswire.com,
www.calcalist.co.il,
www.israel21c.org.
What does Restore Medical do?
Restore Medical is dedicated to improve the treatment of congestive heart failure (CHF) by developing innovative and disruptive medical device that will reduce hospitalizations, mortality, and morbidity. The company has developed the first and only transcatheter Pulmonary Artery Banding (PAB) system for the treatment of HFrEF patients. ContraBand is an innovative and reversible therapy for the treatment of left ventricle (LV) failure. The catheter-delivered implant is designed to leverage the right ventricle (RV) to provide support to the LV, improving LV ejection fraction and restoring optimal ventricular geometry. With no approved treatments currently available for this condition, ContraBand has the potential to transform the way congestive heart failure (CHF) patients are treated. Ongoing Clinical trial have demonstrated that ContraBand is a highly effective and safe treatment for patients with LV failure. The implantation procedure for ContraBand is simple and time effective.
How much funding has Restore Medical raised?
Restore Medical has raised $29.43M in total funding across 5 rounds. The company is currently at the B stage. Key investors include Pitango HealthTech, Peregrine Ventures, European Union’s EIC Fund.
Who founded Restore Medical?
Restore Medical was founded in 2015 by Elchanan Bruckheimer (Co-founder & CMO), Stephen Bellomo (Co-founder & VP Clinical Afffairs).
What sector is Restore Medical in?
Restore Medical operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Restore Medical located?
Restore Medical is based in Yehonatan Netanyahu Street 6, Or Yehuda, Israel, Center District.